ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
KalVista Pharmaceuticals Inc

KalVista Pharmaceuticals Inc (4XC1)

0,00
0,00
( 0,00% )
Mis à jour : -

KalVista Pharmaceuticals Inc (4XC1) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
-
( - )
Prix Achat
-
Prix Vente
-
Volume échangé
-
0,00 Fourchette du Jour 0,00
9,05 Plage de 52 semaines 23,14
Cap du marché
Clôture Veille
-
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
3 517 213 €
Actions en circulation
53 240 888
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-10,78
Bénéfice par action (BPA)
-2,51
Chiffre d'affairess (LTM)
114,48M
Bénéfice net (LTM)
-135,94M

À propos de KalVista Pharmaceuticals Inc

As of June 11, 2026, KalVista Pharmaceuticals, Inc. was taken private. KalVista Pharmaceuticals, Inc. operates as a biopharmaceutical company that develops oral therapies for rare diseases in worldwide markets. It offers sebetralstat, a novel, oral, on-demand treatment for hereditary angioedema (HAE... As of June 11, 2026, KalVista Pharmaceuticals, Inc. was taken private. KalVista Pharmaceuticals, Inc. operates as a biopharmaceutical company that develops oral therapies for rare diseases in worldwide markets. It offers sebetralstat, a novel, oral, on-demand treatment for hereditary angioedema (HAE), and an oral Factor XIIa inhibitor program. KalVista Pharmaceuticals, Inc. was formerly known as KalVista Pharmaceuticals Ltd. and changed its name to KalVista Pharmaceuticals, Inc. in November 2016. KalVista Pharmaceuticals, Inc. is headquartered in Framingham, Massachusetts. As of June 11, 2026, KalVista Pharmaceuticals, Inc. operates as a subsidiary of Chiesi Farmaceutici S.p.A. Show more

Secteur
-
Industrie
-
Site Web
Siège social
Framingham, United States
Fondé
-
KalVista Pharmaceuticals Inc est coté dans le secteur de la Tradegate (DE) avec le ticker 4XC1. Le dernier cours de clôture d'KalVista Pharmaceuticals était de -. Au cours de la dernière année, les actions de KalVista Pharmaceuticals ont été négociées dans une fourchette de prix de 9,05 € à 23,14 €.

KalVista Pharmaceuticals compte actuellement 53 240 888 actions en circulation. KalVista Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -10.78.

4XC1 Dernières nouvelles

Aucune actualité à afficher pour le moment.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000DE
40022.623.1422.0833223.00314475DE
12001423.141495520.52886058DE
26001423.1411.590016.8278869DE
520011.123.149.05151812.9496198DE
156009.823.146.9105012.63934057DE
260009.823.146.9105012.63934057DE

4XC1 - Frequently Asked Questions (FAQ)

What is the current KalVista Pharmaceuticals Inc share price?
The current share price of KalVista Pharmaceuticals Inc is 0,00 €
How many KalVista Pharmaceuticals Inc shares are in issue?
KalVista Pharmaceuticals Inc has 53 240 888 shares in issue
What is the 1 year trading range for KalVista Pharmaceuticals Inc share price?
KalVista Pharmaceuticals Inc has traded in the range of 9,05 € to 23,14 € during the past year
What is the PE ratio of KalVista Pharmaceuticals Inc?
The price to earnings ratio of KalVista Pharmaceuticals Inc is -10,78
What is the cash to sales ratio of KalVista Pharmaceuticals Inc?
The cash to sales ratio of KalVista Pharmaceuticals Inc is 12,56
What is the registered address of KalVista Pharmaceuticals Inc?
The registered address for KalVista Pharmaceuticals Inc is 200 Crossing Boulevard, Framingham, Massachusetts, 01702
What is the KalVista Pharmaceuticals Inc website address?
The website address for KalVista Pharmaceuticals Inc is www.kalvista.com

4XC1 Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion